Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2000
07/05/2000EP1014983A1 Naproxen/cetirizine compositions and methods for treating respiratory disorders
07/05/2000EP1014982A1 Troglitazone compounds for treating climacteric
07/05/2000EP1014981A1 Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime
07/05/2000EP1014980A1 Use of nitroxides for the treatment of essential hypertension
07/05/2000EP1014979A1 Compounds with combined antihistaminic and mast cell stabilizing activities, intended for ophthalmic use
07/05/2000EP1014978A1 Method of using neutrophic sulfonamide compounds
07/05/2000EP1014977A1 Diagnosis of migraine with aura, depression and anxiety from allelic variations in dopaminergic genes
07/05/2000EP1014976A1 Novel substituted imidazole compounds
07/05/2000EP1014975A1 Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine
07/05/2000EP1014974A1 Treatment of schizophrenia and psychosis
07/05/2000EP1014973A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
07/05/2000EP1014972A1 Method of treatment and pharmaceutical composion
07/05/2000EP1014971A1 Treatment for premenstrual dysphoric disorder
07/05/2000EP1014970A1 Parasiticidal formulations
07/05/2000EP1014969A1 Plant proanthocyanidin extract effective at inhibiting adherence of bacteria with p-type fimbriae to surfaces
07/05/2000EP1014968A1 NARINGIN AND NARINGENIN AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR
07/05/2000EP1014967A1 Use of zinc salts of conjugated linoleic acids to treat skin disorders
07/05/2000EP1014966A1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
07/05/2000EP1014965A1 Dietary compositions for enhancing metabolism and alleviating oxidative stress
07/05/2000EP1014964A1 Melanins with improved ability to inhibit hiv replication
07/05/2000EP1014963A1 Use of sulphonanilide derivatives to obtain a medicine for treating retrograde ejaculation or aspermia
07/05/2000EP1014962A1 Antithrombotic agents
07/05/2000EP1014961A1 Improved treatment of migraine headache
07/05/2000EP1014960A1 Use of a specific antagonist of 5ht2 receptors for preparing medicines useful for treating sleep-disordered breathing
07/05/2000EP1014959A1 Agmatine as a treatment for neuropathic pain
07/05/2000EP1014957A1 Urinary incontinence therapy
07/05/2000EP1014956A1 Methods of using integrin modulators
07/05/2000EP1014955A1 New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising terbutaline sulphate, a process for preparing the formulation and the use thereof
07/05/2000EP1014954A2 Transdermal therapeutic system
07/05/2000EP1014953A2 Formulations for hydrophobic pharmaceutical agents
07/05/2000EP1014952A1 Multiple unit effervescent dosage form
07/05/2000EP1014950A1 Dosage forms exhibiting multiphasic release kinetics and methods of manufacture thereof
07/05/2000EP1014949A1 Rapidly disintegrating methylcellulose tablets
07/05/2000EP1014947A1 Method of preparing pharmaceutical compositions of lipid particles comprising a lipid agent and a protein
07/05/2000EP1014946A1 Sustained-release liposomal anesthetic compositions
07/05/2000EP1014945A1 Cationic lipid compositions targeting angiogenic endothelial cells
07/05/2000EP1014943A1 Medical aerosol formulations
07/05/2000EP1014942A1 Non-steroidal antiinflammatory drug formulations for topical application to the skin
07/05/2000EP1014940A1 Ophthalmic composition including a cationic glycoside and an anionic therapeutic agent
07/05/2000EP1014927A1 Use of shogaols and gingerols for preparing deodorant compositions
07/05/2000EP1014926A1 Therapeutic and cosmetic compositions, their use and method for the preparation thereof
07/05/2000EP1014886A1 Synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor
07/05/2000EP1014876A1 Method for removing superfluous hairs
07/05/2000EP1014812A1 Smoking products containing antioxidants
07/05/2000EP1014808A1 Fatty acids as a diet supplement
07/05/2000EP1014804A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
07/05/2000EP1014791A1 Method for lowering serum lipid levels employing an mtp inhibitor in combination with another cholesterol lowering drug
07/05/2000EP0900234B1 21-substituted progesterone derivatives as new antiprogestational agents
07/05/2000EP0876392B1 Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives
07/05/2000EP0866874B1 Process for the preparation of materials with a high content of isomers of conjugated linoleic acid
07/05/2000EP0821676B1 3-phenyl-1,4-dialkyl-1,2,4-triazolium salts and their use as antidepressants
07/05/2000EP0793496B1 USE OF HALOGENATED beta-CARBOLINES AS MODEL SUBSTANCES TO PRODUCE NEURODEGENERATIVE DISORDERS
07/05/2000EP0788490B1 Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis
07/05/2000EP0786936B1 Method for reducing bacterial contamination in an aquaculture
07/05/2000EP0759754A4 A method of modifying angiotensin receptor activity for treatment of premenstrual syndrome and mediation of pain
07/05/2000EP0755396B1 Stable aqueous folinate solution
07/05/2000EP0736018B1 4,5-diaryloxazole derivatives
07/05/2000EP0734381B1 Morpholine tachykinin receptor antagonists
07/05/2000EP0726895B1 Pseudodipeptide product having an imidazole grouping and applications
07/05/2000EP0726894B1 Short-acting dihydropyridines
07/05/2000EP0711296B1 IMIDAZOLYLALKYL DERIVATIVES OF IMIDAZOL[5,1-c][1,4]BENZOXAZIN-1-ONE AND THEIR USE AS THERAPEUTIC AGENTS
07/05/2000EP0711293B1 IMIDAZOLYLALKYL DERIVATIVES OF IMIDAZO[1,5-a]INDOL-3-ONE AND THEIR USE AS THERAPEUTIC AGENTS
07/05/2000EP0686151B1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
07/05/2000EP0680322B1 Use of clavulanate and an antibacterial compound for the treatment of infections
07/05/2000EP0679080B1 L-arginine and analogues as thrombocyte aggregation inhibitors
07/05/2000EP0675889B1 Antiallergic triazolo(pyrrolo, thieno or furano)azepine derivatives
07/05/2000EP0675886B1 Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists
07/05/2000EP0637241B1 Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic
07/05/2000EP0626961B1 Process for the preparation of cyano-methoxyiminomethyl derivatives
07/05/2000EP0570414B1 Naphthoquinone derivatives for the treatment of chronic inflammation
07/05/2000EP0565621B1 Method of making camptothecin and camptothecin analogs
07/05/2000EP0563168B1 Xanthine derivatives
07/05/2000EP0554436B1 Gaba receptor modulators
07/05/2000EP0528891B1 Method for increasing blood-brain barrier permeability
07/05/2000CN1259165A Modulators of intracellular inflamation, cell death and cell survival pathways containing a card and kinase domain
07/05/2000CN1259143A Oligosaccharide mixtures having antithrombotic activity
07/05/2000CN1259138A 17 'beta'-allyloxy (thio) alkyl-androstane derivatives for the modulation of meiosis
07/05/2000CN1259137A Estra-5(10), 7-dienes with estrogenic activity
07/05/2000CN1259136A 4'-substituted-9-deoxo-9A-AZA-9A-homoerythromycin a derivatives
07/05/2000CN1259135A 9-oxime erythromycin derivatives
07/05/2000CN1259134A Novel class of nucleic acid cationic transfecting agents
07/05/2000CN1259132A Compounds
07/05/2000CN1259131A Compounds
07/05/2000CN1259130A Preparation of isoflavones from legumes
07/05/2000CN1259129A Desoxycyclodepsipeptides and their use for combatting endoparasites
07/05/2000CN1259128A Thiodepsipeptides for combating endoparasites and a method for producing the same
07/05/2000CN1259127A Crystal modification of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and its use as antiepileptic
07/05/2000CN1259126A Pharmacological agents
07/05/2000CN1259125A Substituted 3-cyano quinolines
07/05/2000CN1259120A Calcilytic compounds
07/05/2000CN1259119A Substituted 3,3-diamino-2-propenenitriles their preparation and use
07/05/2000CN1259117A 2-aminopropane-1,3-diol compounds medicinal use thereof and intermediates in synthesizing the same
07/05/2000CN1259053A Medicinal composition
07/05/2000CN1259050A Composition comprising 5-[4-(2-(N-methyl-N-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione
07/05/2000CN1259049A Carboxamides useful as 5-HT1F agonists
07/05/2000CN1259048A Semisolid pharmaceutical formulation containing dexketoprofen trometamol
07/05/2000CN1259047A Antiallergic agents
07/05/2000CN1259043A Cosmetic and/or dermatological composition containing a derivative of methylated silanol and a derivative of hydrolysed plant protein
07/05/2000CN1259041A Compositions comprising santalins, santarubins for artificially coloring the skin
07/05/2000CN1259040A Compositions and methods for inhibiting photoaging of skin